Human seminal plasma suppresses lymphocyte responses in vitro in serum-free medium. 1987

S Szymaniec, and A J Quayle, and T B Hargreave, and K James
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, UL Czerska, Wroclaw, Poland.

The in vitro immunosuppressive properties of human seminal plasma have been re-investigated in serum-free medium in view of recent suggestions that the previously observed effects might be dependent on the presence of exogenous serum co-factors present in the culture media. The present studies reveal that low concentrations of seminal plasma can inhibit the ability of peripheral blood leukocytes to lyse K562 target cells in the absence of fetal calf or new-born calf serum. These inhibitory effects could be achieved by pre-incubating the effector cells in seminal plasma at 37 degrees C prior to use in the natural killer cell assay or by incorporating it into the assay system. Additional studies revealed that human seminal plasma could also inhibit the proliferative response of peripheral blood lymphocytes to phytohaemagglutinin in serum-free HB103 medium. These effects were most marked and consistent if the seminal plasma was present throughout the period of culture. Overall, these studies indicate that the previously reported suppressive effects of human seminal plasma in these systems cannot be entirely attributable to cytotoxic factors generated by exogenous serum components.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012661 Semen The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma. Seminal Plasma,Plasma, Seminal
D013491 Suppressor Factors, Immunologic Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-J) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. Immunologic Suppressor Factors,Suppressor T-Cell Factors,T-Cell Suppressive Factors,T-Suppressor Factors,Factors, Immunologic Suppressor,Factors, T Suppressor,Suppressor Factor (SF4),T Cell Suppressor Factors,Factors, Suppressor T-Cell,Factors, T-Cell Suppressive,Factors, T-Suppressor,Suppressive Factors, T-Cell,Suppressor Factors, T,Suppressor T Cell Factors,T Cell Suppressive Factors,T Suppressor Factors,T-Cell Factors, Suppressor
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

S Szymaniec, and A J Quayle, and T B Hargreave, and K James
October 1986, Clinical and experimental immunology,
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
April 1973, Clinical immunology and immunopathology,
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
April 1971, Lancet (London, England),
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
January 1979, Journal of immunological methods,
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
September 1994, Journal of immunological methods,
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
January 1998, Journal of investigational allergology & clinical immunology,
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
May 1977, Journal of immunology (Baltimore, Md. : 1950),
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
June 1981, International journal of andrology,
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
September 1981, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
S Szymaniec, and A J Quayle, and T B Hargreave, and K James
April 2002, Endocrine,
Copied contents to your clipboard!